Synthetic Biologics, Inc. (NYSE: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE